Loading...

Blog Post

Ghana Citizenship > News > Healthcare > Ghana’s New Pharmaceutical Park Could Create Thousands of Jobs: What LePIP Is and Who Can Apply
Ghana Pharmaceutical Park jobs and manufacturing project at Osudoku Ningo Prampram

Ghana’s New Pharmaceutical Park Could Create Thousands of Jobs: What LePIP Is and Who Can Apply

Ghana is moving forward with plans for a major pharmaceutical manufacturing and life sciences hub that the government says could eventually support tens of thousands of jobs.

The Legon Pharmaceutical Innovation Park, commonly called LePIP, is planned as a 2,000-acre pharmaceutical and life sciences ecosystem in the Osudoku/Ningo Prampram area of the Greater Accra Region.

The first phase is expected to begin with a roughly 40-hectare manufacturing platform. Ghana’s 24-Hour Economy and Accelerated Export Development Programme says the initial phase could create more than 3,000 direct jobs, while subsequent phases could generate an estimated 30,000 additional jobs, alongside indirect employment in manufacturing, logistics, packaging, engineering, research and related industries.

However, people searching for Ghana Pharmaceutical Park jobs should understand an important distinction: there is currently no general recruitment exercise for 30,000 workers.

The application process now underway is for pharmaceutical manufacturers and other eligible businesses that want to establish operations within the park. Employment opportunities would develop as the park is built and companies begin operating.

Here is what is currently known about LePIP, where it will be located, what companies can participate, what kinds of jobs could eventually be created and when actual employment opportunities may begin appearing.

 

 

 

What Is the Legon Pharmaceutical Innovation Park?

The Legon Pharmaceutical Innovation Park is a planned industrial and research ecosystem intended to expand pharmaceutical manufacturing in Ghana.

The project is being developed under Ghana’s 24-Hour Economy and Accelerated Export Development Programme, commonly referred to as 24H+, in collaboration with the Ghana Infrastructure and Investment Fund.

Government describes LePIP as Ghana’s first integrated pharmaceutical innovation park.

The idea is to create a single industrial environment where pharmaceutical manufacturers, research institutions, testing laboratories, logistics companies and related life sciences businesses can operate with access to shared infrastructure.

Instead of every pharmaceutical company having to independently build expensive utilities, laboratories, warehousing and treatment systems, the park is intended to provide much of that infrastructure centrally.

That could reduce the cost and time required for companies to establish pharmaceutical manufacturing operations in Ghana.

 

Where Will Ghana’s Pharmaceutical Park Be Located?

Current 2026 project information places LePIP in the Osudoku/Ningo Prampram enclave in the Greater Accra Region.

The larger project is planned across approximately 2,000 acres.

The first development stage is expected to begin with a roughly 40-hectare pilot manufacturing platform.

The location is intended to provide manufacturers with access to Greater Accra’s workforce, transport connections, research institutions, regulatory bodies and the wider Accra-Tema industrial economy.

 

Will the Pharmaceutical Park Really Create 30,000 Jobs?

The 30,000 figure is a government projection, not a count of currently available positions.

The latest official 24H+ information provides a more detailed breakdown than some early news reports.

Employment Stage Government Projection
First phase More than 3,000 direct jobs
Subsequent phases Approximately 30,000 additional jobs
Indirect employment Several thousand additional opportunities anticipated

The final number will depend on how many companies actually invest, how many factories are constructed, which products are manufactured and how quickly later phases of the park are completed.

For that reason, the 30,000 figure should be understood as an employment target or projection rather than a guaranteed number of jobs.

 

Are the 30,000 Pharmaceutical Park Jobs Open for Applications?

No general recruitment exercise for 30,000 workers has been announced.

The current application process is an Expression of Interest for businesses that want to become tenants at LePIP.

It is not a job application.

This distinction is important because headlines referring to “30,000 jobs” can make it sound as though the government is currently recruiting thousands of workers.

Actual employment opportunities are more likely to emerge in stages as:

  • Construction begins.
  • Infrastructure is installed.
  • Pharmaceutical companies sign leases.
  • Factories are constructed or fitted out.
  • Manufacturing lines begin operating.
  • Research and laboratory facilities open.
  • Logistics and support companies establish operations.

People interested in future employment should monitor the 24-Hour Economy Programme, participating pharmaceutical companies and Ghanaian job platforms as development progresses.

You can also see our guide to finding jobs in Ghana.

 

What Types of Jobs Could LePIP Create?

A pharmaceutical manufacturing park requires considerably more than pharmacists.

If the project develops as planned, employment could span manufacturing, science, engineering, logistics, administration and support services.

Potential job categories could include:

  • Pharmacists.
  • Industrial pharmacists.
  • Chemists.
  • Biochemists.
  • Microbiologists.
  • Laboratory scientists.
  • Quality-control specialists.
  • Quality-assurance officers.
  • Manufacturing technicians.
  • Production operators.
  • Mechanical engineers.
  • Electrical engineers.
  • Process engineers.
  • Maintenance technicians.
  • Packaging workers.
  • Warehouse workers.
  • Cold-chain specialists.
  • Supply-chain professionals.
  • Drivers and logistics workers.
  • Regulatory affairs professionals.
  • Research scientists.
  • Data and laboratory technicians.
  • Administrative staff.
  • Security personnel.
  • Cleaning and facility-management workers.

The exact positions will depend on the companies that eventually establish operations in the park.

No official vacancy list covering all of these occupations has been published.

 

What Will Companies Manufacture at LePIP?

The park is designed to accommodate several parts of the pharmaceutical and life sciences industry.

The current Expression of Interest invites companies involved in areas including:

Industry Examples
Active pharmaceutical ingredients Core chemical or biological ingredients used to manufacture medicines
Generic and essential medicines Common medicines used by hospitals, clinics and consumers
Vaccines and biologics Vaccines and biologically produced medical products
Nutraceuticals Nutrition and health-related products
Herbal medicines Standardized medicinal products derived from plants
Diagnostics Medical tests and diagnostic products
Medical devices Equipment and devices used in healthcare

Joint ventures and business consortia are also eligible to express interest.

 

What Facilities Will the Pharmaceutical Park Provide?

One of the central ideas behind LePIP is shared infrastructure.

Pharmaceutical factories operate under strict manufacturing and environmental requirements. Building those systems individually can require substantial capital.

Planned shared facilities at the park include:

  • Reliable electricity.
  • Industrial water supply.
  • Steam systems.
  • Good Manufacturing Practice-compliant infrastructure.
  • Centralized quality-control laboratories.
  • Testing laboratories.
  • Cold-chain storage.
  • Warehousing.
  • Ready-built factory shells.
  • Effluent treatment facilities.
  • Environmental management infrastructure.
  • Logistics services.
  • Regulatory support.
  • Digital infrastructure.
  • Research and innovation facilities.

Businesses operating within the park would generally pay fees or lease charges for access to shared services.

 

How Will Ghana Train Workers for the Pharmaceutical Park?

The project includes plans for a Pharmaceutical Manufacturing Centre of Excellence in partnership with the University of Ghana.

The Centre is intended to help bridge the gap between university education and the specialized technical skills required by pharmaceutical manufacturers.

The 24H+ Secretariat says the Centre is targeting the development of more than 1,000 industry-ready workers during its first five years.

The wider project is also expected to involve University of Ghana research institutions and pharmaceutical training programs.

That could create opportunities for students and graduates in pharmacy, chemistry, biology, engineering and related fields to gain more industry-specific training.

The university partnership is especially important because pharmaceutical production requires workers who understand regulated manufacturing standards, laboratory procedures, product quality and documentation.

 

Why Is Ghana Building a Pharmaceutical Manufacturing Park?

Ghana continues to import most of the pharmaceutical products used in the country.

The current LePIP Expression of Interest estimates that approximately 70% of Ghana’s pharmaceutical requirements are imported.

Earlier project material placed the annual cost of those imports at more than US$300 million.

The government has set a target of replacing approximately 50% of imported pharmaceutical products with locally manufactured alternatives by 2030.

Increasing domestic production could potentially:

  • Reduce reliance on imported medicines.
  • Reduce exposure to foreign exchange shortages.
  • Strengthen pharmaceutical supply security.
  • Create manufacturing jobs.
  • Develop local technical expertise.
  • Support Ghanaian research.
  • Increase pharmaceutical exports.

The government also wants Ghanaian manufacturers to serve markets beyond Ghana.

 

How Large Is Ghana’s Pharmaceutical Market?

The 24-Hour Economy Secretariat estimates Ghana’s pharmaceutical market at more than US$700 million.

It projects that the market could exceed US$1 billion by 2030.

That projected growth is one reason government is trying to attract manufacturers before demand expands further.

The park is also being designed with exports in mind.

Companies operating in Ghana can potentially target the wider ECOWAS and African Continental Free Trade Area markets, although actual export access will depend on product registration, regulatory approval, trade rules and the individual destination market.

 

Which Businesses Can Apply to Establish Operations at LePIP?

The current Expression of Interest is aimed at pharmaceutical manufacturers and allied life sciences companies.

Eligible areas include active pharmaceutical ingredients, generic medicines, vaccines, biologics, herbal products, nutraceuticals, diagnostics and medical devices.

Joint ventures and consortia may also submit expressions of interest.

The government is looking for potential tenants rather than simply contractors.

This means companies selected through the process could eventually establish manufacturing or related operations inside the park.

Anchor tenants may also be considered for equity participation in the project’s special purpose vehicle, subject to final negotiations and terms.

 

What Is the Current LePIP Application Deadline?

The deadline for prospective companies has been extended to:

October 31, 2026

The original deadline was October 12.

The 24-Hour Economy and Accelerated Export Development Programme extended the period to give additional pharmaceutical manufacturers and life sciences businesses time to submit Expressions of Interest.

Interested companies can obtain the application information through the official 24-Hour Economy and Accelerated Export Development Programme website.

 

Does Submitting an Expression of Interest Guarantee a Company Space?

No.

The government has specifically stated that the current Expression of Interest is not a tender.

Submitting an application does not automatically:

  • Grant a lease.
  • Award a contract.
  • Guarantee factory space.
  • Create an equity right.
  • Guarantee government funding.

The EOI is intended to identify businesses interested in participating in the project.

Companies that move forward can then enter more detailed discussions about tenancy, infrastructure requirements, investment and commercial terms.

 

What Does LePIP Mean for Investors?

LePIP could eventually create opportunities well beyond pharmaceutical manufacturing itself.

A large manufacturing park requires suppliers and service companies in areas such as:

  • Construction.
  • Industrial equipment.
  • Packaging.
  • Transportation.
  • Warehousing.
  • Cold-chain logistics.
  • Waste treatment.
  • Energy.
  • Water treatment.
  • Laboratory services.
  • Information technology.
  • Facility management.
  • Professional services.

Those opportunities will depend on the project’s development and procurement structure.

Foreign investors interested in establishing a Ghanaian business can also see our guide to business registration for foreign investors in Ghana.

 

When Will Ghana’s Pharmaceutical Park Open?

A final opening date for the completed 2,000-acre park has not been publicly confirmed in the current project material reviewed by GhanaCitizenship.com.

The project is being developed in phases.

The present focus is attracting prospective tenants and developing the initial manufacturing platform.

Before large-scale production and hiring can occur, several steps still have to happen, including:

  • Tenant selection.
  • Commercial negotiations.
  • Infrastructure development.
  • Factory construction or fit-out.
  • Equipment installation.
  • Regulatory approval.
  • Employee recruitment.
  • Manufacturing licensing.

That means the 30,000-job projection should be viewed as a medium- to long-term economic-development target rather than an immediate employment event.

 

How Can Job Seekers Prepare for Future LePIP Jobs?

People interested in working in Ghana’s pharmaceutical industry can begin preparing before formal recruitment starts.

Technical qualifications likely to be useful across the industry include pharmacy, chemistry, biology, microbiology, engineering, laboratory science, supply-chain management and manufacturing technology.

Applicants with experience in Good Manufacturing Practice environments, quality control, quality assurance or regulated production may also be attractive to future manufacturers.

People without scientific degrees should not assume the park will have no opportunities for them.

Large manufacturing facilities also require logistics, security, maintenance, administration, warehousing, transportation, cleaning, information technology and other support functions.

The most important thing is to wait for genuine vacancies from the participating employers rather than paying individuals who claim they can guarantee employment before the factories have begun recruiting.

 

Be Careful With Fake Pharmaceutical Park Job Offers

Large employment announcements often attract unofficial recruitment offers.

At the time this article was updated, the government was seeking businesses and investors for LePIP, not conducting a public recruitment exercise for 30,000 employees.

Be cautious if someone:

  • Promises a guaranteed pharmaceutical park job for payment.
  • Requests money through a personal mobile money account.
  • Claims the 30,000 positions are already open without providing an official vacancy notice.
  • Requests passport or identity documents through an unofficial social media account.
  • Claims to have a government recruitment form that cannot be found through official channels.

Verify vacancies directly with the employer, the 24-Hour Economy Programme or another official source before submitting money or sensitive information.

 

What Should We Watch Next?

The October 31 Expression of Interest deadline is only an early stage of the project.

The next milestones will provide a clearer indication of how quickly LePIP is moving from planning into actual industrial development.

Important developments to watch include:

  • Which pharmaceutical companies are selected as tenants.
  • Whether international manufacturers commit investment.
  • When construction of the first manufacturing phase begins.
  • The final cost and financing structure.
  • When factories begin recruiting workers.
  • Which medicines and medical products will be manufactured first.
  • How many Ghanaian pharmaceutical companies participate.
  • Whether the project begins reducing medicine imports.
  • When the Pharmaceutical Manufacturing Centre of Excellence starts training workers.
  • When the first locally manufactured products leave the park.

 

Bottom Line

Ghana’s planned Legon Pharmaceutical Innovation Park is a major attempt to build a domestic pharmaceutical manufacturing industry around shared infrastructure, research, training and industrial production.

The project is planned as a 2,000-acre pharmaceutical and life sciences ecosystem in the Osudoku/Ningo Prampram area, beginning with a smaller first-phase manufacturing platform.

Government currently projects more than 3,000 direct jobs during the first phase and approximately 30,000 additional jobs in subsequent phases, with further employment expected in supporting industries.

Those jobs are not currently available as one large recruitment exercise.

The immediate October 31 application deadline is for pharmaceutical manufacturers and related businesses interested in establishing operations inside the park.

For job seekers, the important moment will come later, when companies are selected, factories are developed and individual employers begin advertising vacancies.

 

Sources